Search
Search Results
##search.searchResults.foundPlural##
-
RECENT ADVANCES IN THE 5Q- SYNDROME
3223PDF: 1989HTML: 3861Pellagatti Fig 1: 299Pellagatti Fig. 2: 281 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3555PDF: 1054HTML: 5012 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2765PDF: 1315HTML: 1140 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
4003PDF: 1753HTML: 901Figures . Eliassian: 351 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2795PDF: 912HTML: 5412 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1796HTML: 737PDF: 954 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2774PDF: 1861HTML: 747 -
Pseudo-differentiation syndrome
1586PDF: 759HTML: 10895Figure 1: peripheral blood showing myeloblasts with auer rods: 181Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 154Figure 3: CXR showing pulmonary infiltartes with consolidation: 183Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 162Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 161 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2542PDF: 1966HTML: 1098 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
4218PDF: 856HTML: 1910 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3905PDF: 2695HTML: 1733 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
5056PDF: 1983HTML: 2233 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
4059PDF: 1814HTML: 12000Figures Haase: 332 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2187PDF: 2059HTML: 816 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
4070PDF: 1632HTML: 369 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
2132PDF: 1162HTML: 292 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1938PDF: 1029HTML: 1214Untitled: 229Untitled: 241Untitled: 240Untitled: 220 -
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS: LOW INCIDENCE OF PRIMARY NEOPLASM AS A TRIGGER IN A CASE SERIES FROM TURKEY
1756PDF: 1042HTML: 276Figure 1: 229 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4889PDF: 4004HTML: 385 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1937PDF: 969HTML: 489Fig1: 303Fig.2: 350Fig. 3: 268Fig. 5: 291Fig. 4: 304 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3157PDF: 1133HTML: 5689 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1350PDF: 684HTML: 2935ATRA induced Reactive Hemophagocytosis: A Case Report: 269 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
2075PDF: 929HTML: 10382Figures 1,2,3: 352 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1696PDF: 1008Suppl. Files: 507HTML: 318 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
8035PDF: 2553HTML: 2185Table 1.: 300Table 2.: 326Table 3.: 280Table 4.: 288 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1325PDF: 976HTML: 314 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1455PDF: 981HTML: 1220Coverletter: 319 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3721PDF: 1007HTML: 1728figure 1: 227Untitled: 258 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13451PDF: 1082HTML: 7345 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1376PDF: 603HTML: 23270 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3281PDF: 1143HTML: 3385 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1935PDF: 648HTML: 17011Figure 4: 250Figure 3: 211Figure 2: 211Figure 1: 237 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1682PDF: 1055HTML: 279 -







